Borgeson Blake sold RXRX
December 2, 2025 · Form 4 insider transaction
Borgeson Blake sold 220,000 shares of Recursion Pharmaceuticals, Inc. at $4.37 per share, a transaction worth $961.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
220,000
Price
$4.37
Total value
$961.4K
InsiderBorgeson Blake
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateDecember 2, 2025
Filing dateDecember 4, 2025
Shares owned after6,869,863
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.